Gene · 6375
Papers2,385
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
581 to 600 of 2,385
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Targeting histone deacetylase-3 blocked epithelial-mesenchymal plasticity and metastatic dissemination in gastric cancer. | Cell Biol Toxicol | 2023 | 34973135 | PubTator, text mining | PubMed |
| The role of innate immune cells in the tumor microenvironment and research progress in anti-tumor therapy. | Front Immunol | 2022 | 36741415 | PubTator, text mining | PubMed |
| Multimodal human thymic profiling reveals trajectories and cellular milieu for T agonist selection. | Front Immunol | 2022 | 36741401 | PubTator, text mining | PubMed |
| Single-cell analysis of myeloid cells in HPV+ tonsillar cancer. | Front Immunol | 2022 | 36741389 | PubTator, text mining | PubMed |
| IFNα and 5-Aza-2'-deoxycytidine combined with a dendritic-cell targeting DNA vaccine alter tumor immune cell infiltration in the B16F10 melanoma model. | Front Immunol | 2022 | 36741387 | PubTator, text mining | PubMed |
| The roles of chemokines following intracerebral hemorrhage in animal models and humans. | Front Mol Neurosci | 2022 | 36704330 | PubTator, text mining | PubMed |
| Dendritic cells and natural killer cells: The road to a successful oncolytic virotherapy. | Front Immunol | 2022 | 36703982 | PubTator, text mining | PubMed |
| DEF6 has potential to be a biomarker for cancer prognosis: A pan-cancer analysis. | Front Oncol | 2022 | 36686789 | PubTator, text mining | PubMed |
| The association between plasma chemokines and breast cancer risk and prognosis: A mendelian randomization study. | Front Genet | 2022 | 36685922 | PubTator, text mining | PubMed |
| A new natural killer cell-specific gene signature predicting recurrence in colorectal cancer patients. | Front Immunol | 2022 | 36685584 | PubTator, text mining | PubMed |
| Dendritic cell-targeting chemokines inhibit colorectal cancer progression. | Explor Target Antitumor Ther | 2022 | 36654820 | PubTator, text mining | PubMed |
| New insights into the analgesic properties of the XCL1/XCR1 and XCL1/ITGA9 axes modulation under neuropathic pain conditions - evidence from animal studies. | Front Immunol | 2022 | 36618360 | PubTator, text mining | PubMed |
| Phenotypic Characterization of Circulating Tumor Cells Isolated from Non-Small and Small Cell Lung Cancer Patients. | Cancers (Basel) | 2022 | 36612166 | PubTator, text mining | PubMed |
| Obeticholic acid and 5β-cholanic acid 3 exhibit anti-tumor effects on liver cancer through CXCL16/CXCR6 pathway. | Front Immunol | 2022 | 36605219 | PubTator, text mining | PubMed |
| Focusing on NK cells and ADCC: A promising immunotherapy approach in targeted therapy for HER2-positive breast cancer. | Front Immunol | 2022 | 36601109 | PubTator, text mining | PubMed |
| Prospects for NK-based immunotherapy of chronic HBV infection. | Front Immunol | 2022 | 36591230 | PubTator, text mining | PubMed |
| High Hepcidin expression predicts poor prognosis in patients with clear cell renal cell carcinoma. | Diagn Pathol | 2022 | 36585741 | PubTator, text mining | PubMed |
| Mesenchymal stem cell-derived exosomes: The dawn of diabetic wound healing. | World J Diabetes | 2022 | 36578867 | PubTator, text mining | PubMed |
| Effect of repeated bolus and continuous glucose infusion on a panel of circulating biomarkers in healthy volunteers. | PLoS One | 2022 | 36574434 | PubTator, text mining | PubMed |
| Intraepithelial lymphocytes in the pig intestine: T cell and innate lymphoid cell contributions to intestinal barrier immunity. | Front Immunol | 2022 | 36569897 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6375/papers?page=30